This results in decreased calcium influx and smooth muscle relaxation. Dihydropyridine calcium channel blockers act predominantly in the periphery, causing arterial vasodilation. Non ...

Summary. Clevidipine is a new lipophilic, short-acting, third-generation dihydropyridine calcium channel blocker (CCB) approved for use in the management of acute hypertension when oral agents are ...

In this respect, the dihydropyridine class of calcium channel blockers stand out from other calcium channel antagonists. Apart from certain exceptions such as amlodipine, these compounds typically ...

Calcium channel blockers (CCBs) are commonly prescribed ... A study comparing patients poisoned by amlodipine, a dihydropyridine CCB, with those poisoned by non-dihydropyridine CCBs (like ...

In addition, antihypertensive drugs such as α-receptor blockers that can increase mortality in HF should be avoided. The dihydropyridine group of calcium channel blockers are good ...

Calcium channel blocker (CCB) (dihydropyridine). Nifedipine inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. The reduction in calcium influx causes ...

However, it is not effective during physical activity and thus it is recommended to use digoxin in combination with a beta-blocker or non-dihydropyridine calcium channel blocker. Digoxin therapy ...

One surprising finding was that a specific group of calcium channel blockers, known as the non-dihydropyridine class, appeared to be connected to a higher risk of bowel conditions, including ...